Surprise! Surprise! Warhorse has pushed out an unexpected title update for Kingdom Come Deliverance today, April 14. You’re reading that right, this is for the ...
Welcome to Elyses Enchantments on Exercism's JavaScript Track. If you need help running the tests or submitting your code, check out HELP.md. If you get stuck on the exercise, check out HINTS.md, but ...
Welcome to Amusement Park on Exercism's JavaScript Track. If you need help running the tests or submitting your code, check out HELP.md. If you get stuck on the exercise, check out HINTS.md, but try ...
Insomniac Games has released the hotly anticipated New Game+ update for PlayStation 5 exclusive Marvel’s Spider-Man 2, and it adds a number of significant new features to the game. Patch 1.002.000, ...
Fragment founder Hiroshi Fujiwara has steadily been teasing collaborations on both models from Nike’s Mind series and the newest iteration of Air Max over the course of this year. Little did anyone ...
If you purchase an independently reviewed product or service through a link on our website, WWD may receive an affiliate commission. Nike‘s new duo of mind-altering shoes have sold out with each drop ...
Camp4 Therapeutics reported FY25 GAAP EPS of -$2.65, missing expectations, but ended with a robust $109.5 million cash position. Liquidity was significantly strengthened by private placements, equity ...
While Fred Again..’s USB project is ever-expanding, the latest era of it, USB002, ended with Fred’s fourth show at Alexandra Palace last weekend. Now, Fred is putting a cap on the whole thing with a ...
Neoadjuvant combined chemotherapy and immunotherapy for upper tract urothelial carcinoma: Final results from a phase II study. This is an ASCO Meeting Abstract from the 2026 ASCO Genitourinary Cancers ...
Out of nowhere, Rockstar Games has released Red Dead Redemption update 1.002 (complete version 1.002.000), on PS5 and Xbox Series X|S today, February 24. We can confirm this update is only out for ...
A canine health startup called Loyal has now raised more than $250 million to develop drugs that could help dogs—and perhaps one day humans—live longer, healthier lives. The company on February 11 ...
VTx-002 is an experimental gene therapy for ALS that has FDA fast-track designation. It targets toxic TDP-43 protein aggregates, a key driver of ALS progression. The therapy is in a Phase 1/2 clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results